COVID heralds a faster future for drug development (if stakeholders can collaborate)
pharmaphorum
APRIL 8, 2021
Drug development alone is not really working to solve [chronic illness],” he added, noting that BIOS aims to use AI to read these neural signals, find out how they work and eventually control them to produce a therapeutic effect. George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. About the author.
Let's personalize your content